Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01236261
NCT01236261CompletedNot Applicable

Prospective Population Study on Candidemia in Spain (Estudio Poblacional Prospectivo Sobre Candidemia en España)

Fundacion SEIMC-GESIDA29 sites in 1 country730 target enrollmentStarted: March 2013Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
730
Locations
29
Primary Endpoint
Describe fungemia epidemiology in Spain
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of this study is to describe the epidemiology of fungal blood infections in Spain (with emphasis on the incidence, fungal species distribution and antifungal susceptibility). The study is to be performed in five big cities which represent different geographic areas: Barcelona, Bilbao, Madrid, Sevilla and Valencia.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Fungal isolate obtained from blood sample

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Describe fungemia epidemiology in Spain

Time Frame: 1 year

Recollection of demographic variables (age, gender and ethnic origin); clinical variables (background diseases, other coinfections, treatment received, etc) and microbiological information of the isolate.

Secondary Outcomes

  • Correlation between fungemia with a diminished susceptibility fungal strain and clinical evolution(1 year)
  • Describe differences among cities and institutions(1 year)
  • Correlation between reference and commercial microbiological methods(1 year)
  • Determination of the fungal isolates susceptibility to fluconazole, voriconazole, caspofungine, anidulafungine, micafungine and anfotericine B(1 year)
  • Definition of risk factors(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (29)

Loading locations...

Similar Trials

Completed
Not Applicable
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)Candidemia
NCT01174147Merck Sharp & Dohme LLC436
Completed
Not Applicable
Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis FactorsBacteremia
NCT03148769Fundación Pública Andaluza para la gestión de la Investigación en Sevilla5,320
Recruiting
Not Applicable
Spanish Registry of Digestive Tumours RETUDDigestive CancersBile Duct CancerHepatocellular Cancer (HCC)Colorectal Cancer (CRC)Rectal CancerPancreatic Cancer
NCT06711211Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)20,000
Completed
Not Applicable
Surveillance Study of Candiduria in Hospitalized PatientsCandiduria
NCT03910764Taichung Veterans General Hospital536
Completed
Phase 2
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)Candidiasis
NCT00083343Merck Sharp & Dohme LLC48
Prospective Population Study on Candidemia... | Clinical Trial